Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T19:01:12.407Z.
Calculation as of: 2026-10-06T19:01:12.407Z.
Quote observation: 2026-10-06T19:00:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 26be04fabca1f5abb96b6b094ab833c4d2e2f23bc88365d6eea621c26c981704
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$106.91M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.76M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.98M
EV/FCF Ratio
N/A
TTM Avg
22.94x
3Y Avg
13.31x
5Y Avg
10.37x
Market Cap
$105.07M
EV/FCF Ratio
3.55x
TTM Avg
5.56x
3Y Avg
15.97x
5Y Avg
36.28x
Market Cap
$104.62M
EV/FCF Ratio
N/A
TTM Avg
15.12x
3Y Avg
15.12x
5Y Avg
15.12x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $106.91M | N/A | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $107.06M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.59M | N/A | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.76M | N/A | N/A | N/A | N/A |
| Vivani Medical, Inc. (VANI)vs › | $107.79M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | N/A | 22.94x | 13.31x | 10.37x |
| Definitive Healthcare Corp. (DH)vs › | $105.07M | 3.55x | 5.56x | 15.97x | 36.28x |
| Apyx Medical Corporation (APYX)vs › | $109.70M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.62M | N/A | 15.12x | 15.12x | 15.12x |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.18M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
